“weakened immune system”的搜索结果，显示 1661-1670 项，共有 9965 项

1. 肺科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the probable benefit and safety of the LIPOSORBER® LA-15 System for the treatment of adult and pediatric patients ...

2. 神经科- 临床试验- 妙佑医疗国际

   Immune Phenotyping in Amyotrophic Lateral Sclerosis ... A Study of Nervous System Involvement of ... The system (RC+S & PAD) provides intracranial EEG ...

3. 神经科- 临床试验- 妙佑医疗国际

   Immune Phenotyping in Amyotrophic Lateral Sclerosis ... A Study of Nervous System Involvement of ... The system (RC+S & PAD) provides intracranial EEG ...

4. 外科 - 临床试验- 妙佑医疗国际

   ... response. A Study Of Paired-Vagus Nerve Stimulation On Functional Connectivity In Ischemic Stroke. Rochester, Minn. The purpose of this study is to delineate ...

5. MELD（终末期肝病模型）评分 - 妙佑医疗国际

   Dale E, et al. Inconsistent values and algorithmic fairness: a review of organ allocation priority systems in the United States. ... Bednar R, et al. Low back ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... response as the best response achieved with ABBV ... The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer.

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... response as the best response achieved with ABBV ... The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer.

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... response as the best response achieved with ABBV ... The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer.

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Primary Objectives: To estimate the percent of participants who achieve a best response of complete response by the end of the PRV combination therapy in the ...

10. 血液科- 临床试验- 妙佑医疗国际

    Additional cohorts include subjects with B-cell primary or secondary central nervous system (CNS) lymphoma (PCNSL) and (SCNSL), mantle cell lymphoma (MCL) and ...